ARCT-021 single dose priming
ARCT-021-04
Phase 2 mab terminated
Quick answer
ARCT-021 single dose priming for Covid19 is a Phase 2 program (mab) at Arcturus Therapeutics Holdings with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Arcturus Therapeutics Holdings
- Indication
- Covid19
- Phase
- Phase 2
- Modality
- mab
- Status
- terminated